(19)
(11) EP 1 290 230 A2

(12)

(88) Date of publication A3:
23.05.2002

(43) Date of publication:
12.03.2003 Bulletin 2003/11

(21) Application number: 01939609.2

(22) Date of filing: 29.05.2001
(51) International Patent Classification (IPC)7C12Q 1/70, G01N 33/53, A61B 5/055, C07K 16/00
(86) International application number:
PCT/US0117/302
(87) International publication number:
WO 0109/3804 (13.12.2001 Gazette 2001/50)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 02.06.2000 US 209089 P

(71) Applicant: Merck & Co., Inc.
Rahway,New Jersey 07065-0907 (US)

(72) Inventors:
  • CONLEY, Anthony, J.
    Rahway, NJ 07065-0907 (US)
  • MCKENNA, Philip, M.
    Rahway, NJ 07065-0907 (US)
  • PRZYSIECKI, Craig, T.
    Rahway, NJ 07065-0907 (US)
  • KELLER, Paul, M.
    Rahway, NJ 07065-0907 (US)

(74) Representative: Hiscock, Ian James 
European Patent Department,Merck & Co., Inc.,Terlings Park,Eastwick Road
Harlow,Essex CM20 2QR
Harlow,Essex CM20 2QR (GB)

   


(54) HEPATITIS C VIRUS CONJUGATES